Point72 Hong Kong’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,060
Closed -$168K 667
2025
Q1
$168K Buy
+10,060
New +$185K 0.01% 315
2022
Q2
Sell
-10,199
Closed -$132K 2350
2022
Q1
$132K Buy
+10,199
New +$135K ﹤0.01% 1083
2021
Q2
Sell
-15,119
Closed -$278K 2311
2021
Q1
$278K Buy
+15,119
New +$248K 0.01% 979
2019
Q4
Sell
-1,815
Closed -$16K 1425
2019
Q3
$16K Sell
1,815
-4,742
-72% -$41.5K ﹤0.01% 723
2019
Q2
$56K Buy
+6,557
New +$51.8K 0.02% 618
2018
Q1
Sell
-1,247
Closed -$12K 1125
2017
Q4
$12K Sell
1,247
-3,146
-72% -$30.1K 0.01% 468
2017
Q3
$45K Buy
+4,393
New +$40.6K 0.03% 268
2017
Q1
Sell
-399
Closed -$3K 943
2016
Q4
$3K Buy
+399
New +$2.78K ﹤0.01% 756

Other funds holding SEM

Point72 Hong Kong's SEM Position: Q2 2025 in Review

Point72 Hong Kong sold out of Select Medical (SEM) in Q2 2025, closing a stake of 10,060 shares — an estimated $168K sold.

Point72 Hong Kong first reported a position in SEM in Q4 2016 and held it in 8 quarters. The position peaked at $278K in Q1 2021. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.

  • Point72 Hong Kong reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 10,060 Select Medical shares in Q2 2025, an estimated $168K.
  • Point72 Hong Kong first reported a position in Select Medical in Q4 2016 and held it in 8 quarters.
  • Point72 Hong Kong's Select Medical position peaked at $278K in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.